Gene · 1908
Papers2,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders. | World J Diabetes | 2022 | 35800412 | PubTator, text mining | PubMed |
| Association between IKBKAP polymorphisms and Hirschsprung's disease susceptibility in Chinese children. | Transl Pediatr | 2022 | 35800263 | PubTator, text mining | PubMed |
| Examination of Charge Modifications of an Endolysosomal Trapping Inhibitor in an Antagonistic NTSR1-Targeted Construct for Colon Cancer. | Bioconjug Chem | 2022 | 35793523 | PubTator, text mining | PubMed |
| Commentary: Waardenburg syndrome: Genetics and ocular features. | Indian J Ophthalmol | 2022 | 35791203 | PubTator, text mining | PubMed |
| Waardenburg Syndrome Type 1. | Indian J Ophthalmol | 2022 | 35791202 | PubTator, text mining | PubMed |
| Waardenburg syndrome type 4 coexisting with open-angle glaucoma: a case report. | J Med Case Rep | 2022 | 35790984 | PubTator, text mining | PubMed |
| Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. | Nat Chem Biol | 2022 | 35788181 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer. | Cancer Med | 2022 | 35778922 | PubTator, text mining | PubMed |
| Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma. | Technol Cancer Res Treat | 2022 | 35730194 | PubTator, text mining | PubMed |
| Endothelin system expression in the kidney following cisplatin-induced acute kidney injury in male and female mice. | Can J Physiol Pharmacol | 2022 | 35704945 | PubTator, text mining | PubMed |
| Understanding the molecular mechanism of endothelin ETA receptor selecting isopeptides endothelin-1 and -3. | Biophys J | 2022 | 35660104 | PubTator, text mining | PubMed |
| Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors. | Front Genet | 2022 | 35646090 | PubTator, text mining | PubMed |
| Association of Endothelin-Converting Enzyme and Endothelin-1 Gene Polymorphisms with Essential Hypertension in Malay Ethnics. | Genet Res (Camb) | 2022 | 35645613 | PubTator, text mining | PubMed |
| Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response. | Cancer Sci | 2022 | 35639251 | PubTator, text mining | PubMed |
| Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going. | Biology (Basel) | 2022 | 35625487 | PubTator, text mining | PubMed |
| Constraint-Based, Score-Based and Hybrid Algorithms to Construct Bayesian Gene Networks in the Bovine Transcriptome. | Animals (Basel) | 2022 | 35625151 | PubTator, text mining | PubMed |
| A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer. | Front Oncol | 2022 | 35615155 | PubTator, text mining | PubMed |
| The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications. | Arthritis Res Ther | 2022 | 35562771 | PubTator, text mining | PubMed |
| Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting. | Front Endocrinol (Lausanne) | 2022 | 35518926 | PubTator, text mining | PubMed |
| Omics of endothelial cell dysfunction in sepsis. | Vasc Biol | 2022 | 35515704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1908/papers?page=14